The “megalencephaly-capillary malformation” (MCAP) syndrome: The nomenclature of a highly recognizable multiple congenital anomaly syndrome
Version of Record online: 24 JUN 2013
Copyright © 2013 Wiley Periodicals, Inc.
American Journal of Medical Genetics Part A
Volume 161, Issue 8, pages 2115–2116, August 2013
How to Cite
2013. The “megalencephaly-capillary malformation” (MCAP) syndrome: The nomenclature of a highly recognizable syndrome of abnormal brain and body morphogenesis. Am J Med Genet Part A. 161A:2115–2116., .
The preceding Letter by Collins and the ensuing Response by Mirzaa and Dobyns raise the long-standing, never-ending issue regarding the naming of genetic syndromes. Collins (and her parent associates) objects to the recent proposal by Mirzaa et al.  to rename the macrocephaly-capillary malformation syndrome because this change is potentially confusing to families, their care providers, and anyone searching for information on the condition. As Collins points out, this represents the third name change for this entity. Mirzaa et al. proposed using the designation MCAP because megalencephaly (not simply macrocephaly) is a “striking” feature of the condition. This suggestion is compelling because megalencephaly is a more accurate description of this manifestation that occurs consistently in the syndrome.
The naming of genetic syndromes is clearly an age old challenge. Simply peruse most syndrome entries in OMIM to witness the various names for many conditions. The naming of a syndrome by its component features has many limitations (as pointed out in the Letter), most importantly, that one or two of the features rarely captures the essence or clinical spectrum of the entity, oversimplifies designation, and overemphasizes selected manifestations.
However, at the time of original observation and description of a condition, indicating by selected component manifestations is the simplest option. (The use of eponyms in this setting is another important topic but for a future dialogue.) This discourse underscores the need for an international committee that makes consensus recommendations regarding the naming of a syndrome.
John C. Carey
- Issue online: 24 JUL 2013
- Version of Record online: 24 JUN 2013
- Manuscript Accepted: 20 DEC 2012
- Manuscript Received: 17 DEC 2012
- 2003. Mental deficiency, alterations in performance, and CNS abnormalities in overgrowth syndromes. Am J Med Genet C Semin Med Genet 117C:49–56.
- 2007. Neuroimaging findings in macrocephaly-capillary malformation: A longitudinal study of 17 patients. Am J Med Genet Part A 143A:2981–3008. , , , , , , , , , , , , , , , , , , , .
- 2012. Megalencephaly-capillary malformation (MCAP) and megalencephaly-polydactyly-polymicrogyria-hydrocephalus (MPPH) syndromes: Two closely related disorders of brain overgrowth and abnormal brain and body morphogenesis. Am J Med Genet Part A 158A:269–291. , , , , , , , , , , .
- 1997. Macrocephaly-cutis marmorata telangiectatica congenita syndrome: A distinct disorder with developmental delay and connective tissue abnormality. Am J Med Genet 70:67–73. , , , , , , , , , , .
- 2012. De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes. Nat Genet 44:934–940. , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , .
- 2007. Accurately renaming macrocephaly-cutis marmorata telangiectatica congenita (M-CMTC) as macrocephaly-capillary malformation (M-CM). Am J Med Genet Part A 143A:3009. , .